Flagship Ventures Kicks-off its VentureLabs™ Entrepreneurial Fellowship Program

   Flagship Ventures Kicks-off its VentureLabs™ Entrepreneurial Fellowship
                                   Program

Fellows to embark on VentureLabs' unique exploration and venture creation
process

PR Newswire

CAMBRIDGE, Mass., June 20, 2013

CAMBRIDGE, Mass., June 20, 2013 /PRNewswire/ -- Flagship Ventures, a leading
venture capital and venture creation firm focused on healthcare and
sustainability, announced the start of its fifth VentureLabs™Entrepreneurial
Fellowship Program, a unique opportunity for top graduate students to practice
entrepreneuring in the pursuit of world changing venture opportunities.

Building on the success of last year's program, eight talented fellows were
selected to work hand-in-hand with the VentureLabs team this summer to explore
disruptive opportunities in the therapeutics, health technologies,
sustainability and consumer spaces. "The team at VentureLabs has been
perfecting and applying the discipline of entrepreneuring to the venture
creation process for over a decade," said Noubar Afeyan, Managing Partner and
Chief Executive Officer of Flagship Ventures. "Our Fellowship Program serves
not only to scale our venture creation efforts, but also as a means to share
our method of realizing entrepreneurial innovation, and to cultivate
relationships with really talented and driven individuals."

The eight fellows include engineers and scientists pursuing PhDs, MBAs and
Master's degrees with entrepreneurial and technical experience, ideal for
solving the complex scientific and business problems that are explored as part
of the summer fellowship. Fellows will participate in the VentureLabs process
of parallel entrepreneurship and venture creation. "Our mission with the
Fellowship Program is to bring together exceptional innovators from varied
backgrounds to collaborate with our team in nucleating great companies,
providing the fellows with a stimulating and challenging experience unlike any
other," said Harry Wilcox, Chief Operating Officer and General Partner of
Flagship Ventures.

Hundreds of applicants applied to the Fellowship Program from universities
around the world. These fellows were carefully selected from top graduate
programs and represent diverse technical and business backgrounds, skills and
interests.

About Flagship Ventures

Realizing entrepreneurial innovation is the mission of Flagship Ventures. The
firm operates through two synergistic units: VentureLabs™ which invents and
launches transformative companies, and Venture Capital, which finances and
develops innovative, early-stage companies. Founded in 2000, and based in
Cambridge, Massachusetts, Flagship Ventures manages over $900 million in
capital. The Flagship team is active in three principal business sectors:
therapeutics, health technologies and sustainability/clean technology. Past
successful Flagship portfolio companies include: Accuri Cytometers (acquired
by Becton, Dickinson and Company), Adnexus (acquired by Bristol-Myers Squibb),
Hypnion (acquired by Eli Lilly), AVEO (NASDAQ: AVEO), BG Medicine (NASDAQ:
BGMD), Tetraphase (NASDAQ: TTPH), Receptos (NASDAQ: RCPT) and Morphotek
(acquired by Eisai). Additional notable portfolio companies include:
AeroDesigns, Affinnova, Agios, BIND Therapeutics, Joule Unlimited, Quanterix,
and Moderna Therapeutics. For more information, please visit
www.flagshipventures.com.

Contact:

For Flagship Ventures: Rachel Brenner
Ruder Finn
212.715.1623
flagship@ruderfinn.com









SOURCE Flagship Ventures
 
Press spacebar to pause and continue. Press esc to stop.